The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Role for sphingosine kinase 1 in colon carcinogenesis
Open accessAbstract
Sphingosine kinase 1 (SphKl) phosphory‐lates sphingosine to form sphingosine‐l‐phosphate (S1P) and is a critical regulator of sphingolipid‐mediated functions. Cell‐based studies suggest a tumor‐promoting function for the SphK1/S1P pathway. Also, our previous studies implicated the SphK1/S1P pathway in the induction of the arachidonic acid cascade, a major inflammatory pathway involved in colon carcinogenesis. Therefore, we investigated whether the SphK1/S1P pathway is necessary for mediating carcinogenesis in vivo. Here, we report that 89% (42/47) of human colon cancer samples stained positively for SphK1, whereas normal colon mucosa had negative or weak staining. Adenomas had higher expression of SphK1 vs. normal mucosa, and colon cancers with metastasis had higher expression of SphK1 than those without metastasis. In the azoxymethane (AOM) murine model of colon cancer, SphK1 and S1P were significantly elevated in colon cancer tissues compared to normal mucosa. Moreover, blood levels of S1P were higher in mice with colon cancers than in those without cancers. Notably, SphK1 _/_ mice subjected to AOM had significantly less aberrant crypt foci (ACF) formation and significantly reduced colon cancer development. These results are the first in vivo evidence that the SphK1/S1P pathway contributes to colon carcinogenesis and that inhibition of this pathway is a potential target for chemoprevention.—Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y. A., Obeid, L. M. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23, 405‐414 (2009)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y., & Nakaya, R. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90290-h · Cited by 2,401
Processing of gene expression data generated by quantitative real-time RT-PCR.
Muller, P. Y., Janovjak, H., Miserez, A. R., & Dobbie, Z. (2002) · PubMed · Cited by 1,394
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Self-citationBird, R. P. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90157-1 · Cited by 1,031
Kawamori, T., Rao, C. V., Seibert, K., & Reddy, B. S. (1998) · PubMed · Cited by 916
Self-citationSphingosine 1-phosphate signalling in mammalian cells
Pyne, S., & Pyne, N. J. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490385 · Cited by 735
Tanaka, T., Kohno, H., Suzuki, R., Yamada, Y., Sugie, S., & Mori, H. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01386.x · Cited by 729
Discovery and evaluation of inhibitors of human sphingosine kinase.
French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., & Smith, C. D. (2003) · PubMed · Cited by 599
Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720
Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C. A., Mandala, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406512200 · Cited by 447
An oncogenic role of sphingosine kinase
Xia, P., Gamble, J. R., Wang, L., Pitson, S. M., Moretti, P. A. B., Wattenberg, B. W., D'Andrea, R. J., & Vadas, M. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00834-4 · Cited by 394
Pettus, B. J., Bielawski, J., Porcelli, A. M., Reames, D. L., Johnson, K. R., Morrow, J., Chalfant, C. E., Obeid, L. M., & Hannun, Y. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-1038com · Cited by 320
Self-citationPKC-dependent Activation of Sphingosine Kinase 1 and Translocation to the Plasma Membrane
Johnson, K. R., Becker, K. P., Facchinetti, M. M., Hannun, Y. A., & Obeid, L. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203033200 · Cited by 294
Self-citationSphingosine‐1‐phosphate: signaling inside and out
Spiegel, S., & Milstien, S. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01670-7 · Cited by 273
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
Zemann, B., Kinzel, B., Müller, M., Reuschel, R., Mechtcheriakova, D., Urtz, N., Bornancin, F., Baumruker, T., & Billich, A. (2006) · Blood · doi:10.1182/blood-2005-07-2628 · Cited by 264
Sphingosine kinase 1 is up‐regulated in colon carcinogenesis
Kawamori, T., Osta, W., Johnson, K. R., Pettus, B. J., Bielawski, J., Tanaka, T., Wargovich, M. J., Reddy, B. S., Hannun, Y. A., Obeid, L. M., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4331fje · Cited by 217
Self-citationIntracellular Role for Sphingosine Kinase 1 in Intestinal Adenoma Cell Proliferation
Kohno, M., Momoi, M., Oo, M. L., Paik, J.-H., Lee, Y.-M., Venkataraman, K., Ai, Y., Ristimaki, A. P., Fyrst, H., Sano, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02341-05 · Cited by 210
Enhancement of colon carcinogenesis by prostaglandin E2 administration
Kawamori, T. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg033 · Cited by 179
Self-citationSphingosine kinases: A novel family of lipid kinases
Liu, H., Chakravarty, D., Maceyka, M. W., Milstien, S., & Spiegel, S. (2002) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(02)71049-0 · Cited by 159
The Coordination of Prostaglandin E2 Production by Sphingosine-1-phosphate and Ceramide-1-phosphate
Pettus, B. J., Kitatani, K., Chalfant, C. E., Taha, T. A., Kawamori, T., Bielawski, J., Obeid, L. M., & Hannun, Y. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008722 · Cited by 144
Self-citationHansen‐Petrik, M., McEntee, M. F., Jull, B. A., Shi, H., Zemel, M. B., & Whelan, J. (2002) · PubMed · Cited by 143
Billich, A., Bornancin, F., Mechtcheriakova, D., Natt, F., Huesken, D., & Baumruker, T. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.005 · Cited by 139
Distribution of sphingosine kinase activity in mouse tissues: contribution of SPHK1
Fukuda, Y., Kihara, A., & Igarashi, Y. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01551-1 · Cited by 118
Nakatsugi, S., Fukutake, M., Takahashi, M., Fukuda, K., Isoi, T., Taniguchi, Y., Sügimura, T., & Wakabayashi, K. (1997) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1997.tb00337.x · Cited by 94
Cited by
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
Yu, H., Lee, H., Herrmann, A., Buettner, R., & Jove, R. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3818 · Cited by 2,137
Sphingolipids and their metabolism in physiology and disease
Hannun, Y. A., & Obeid, L. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.107 · Cited by 2,051
Self-citationSphingolipid metabolites in inflammatory disease
Maceyka, M., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,277
Sphingolipid metabolism in cancer signalling and therapy
Ogretmen, B. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.96 · Cited by 1,207
An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown
Gault, C. R., Obeid, L. M., & Hannun, Y. A. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-6741-1_1 · Cited by 1,071
Self-citation
Metadata
- Authors
- Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y. A., & Obeid, L. M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2008-09-29
- Volume
- 23
- Issue
- 2
- Pages
- 405-414
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2015354948
- Cited by
- 280
- References
- 25
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.